Related Experiment Video
Updated: Apr 27, 2026
06:10
Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock
Published on: June 12, 2021
2.8K
Mechanical circulatory devices in acute heart failure
Jeffrey J Teuteberg1, Josephine C Chou2
1Heart and Vascular Institute, University of Pittsburgh Medical Center, Scaife Hall, Suite 556, 200 Lothrop Street, Pittsburgh, PA 15213, USA.
Critical Care Clinics
|July 6, 2014
Summary
Cardiogenic shock, a major cause of death, often requires mechanical circulatory support (MCS) when medical therapy fails. This review covers temporary ventricular assist devices for treating acute heart failure and cardiogenic shock.
Area of Science:
- Cardiology
- Cardiovascular Surgery
Background:
- Cardiogenic shock is a significant cause of mortality, even with advancements in myocardial infarction and heart failure treatments.
- Medical management alone is frequently insufficient for patients experiencing cardiogenic shock.
Purpose of the Study:
- To review the application of mechanical circulatory support (MCS) in cardiogenic shock.
- To describe commonly used temporary ventricular assist devices (VADs) and their utilization across different etiologies of cardiogenic shock.
Main Methods:
- Literature review focusing on temporary ventricular assist devices.
- Analysis of the role of MCS in managing acute heart failure and cardiogenic shock.
Main Results:
- Mechanical circulatory support is a critical intervention for patients with cardiogenic shock unresponsive to medical therapy.
- Familiarity with various temporary VADs, their benefits, limitations, and appropriate application is essential for effective treatment.
Conclusions:
- The appropriate use of temporary VADs can improve outcomes for patients with cardiogenic shock.
- Understanding the underlying cause of heart failure and the specifics of device therapy is crucial for successful MCS implementation.
Keywords:
Acute heart failureCardiogenic shockMechanical circulatory supportVentricular assist deviceMore Related Videos
Related Concept Videos
01:30Heart Failure V: Medical Management
621
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
621
01:22Heart Failure VI: Adjunct Therapies
630
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
630
01:30Cardiomyopathy II: Dilated Cardiomyopathy
786
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
786
01:29Cardiomyopathy V: Interprofessional Care
746
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
746
01:29Heart Failure II: Pathophysiology
1.7K
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
1.7K
01:25Cardiopulmonary Resuscitation IV: Pharmacological Management
1.6K
Pharmacologic intervention is crucial in treating cardiac arrest patients during ACLS or Advanced Cardiovascular Life Support. The ACLS algorithms guide the administration of specific drugs based on the patient's cardiac arrest rhythm, which includes pulseless ventricular tachycardia (VT), ventricular fibrillation (VF), asystole, and pulseless electrical activity (PEA).EpinephrineIndication: Epinephrine is the first-line drug for all cardiac arrest rhythms.Mechanism of Action: Epinephrine...
1.6K